Industry Roundup: Nutrilite, No-GMO Similac, Supreme Court, Herbalife VPs
This article was originally published in The Tan Sheet
Nutrilite ingredient granulation expands; GMO-free Similac debuts; Herbalife adds corporate VPs; Supreme Court likely not taking cosmetics preemption case; OTC device claim nixed in U.K.; and more news in brief.
You may also be interested in...
The Supreme Court asks the Solicitor General for an amicus in a case examining whether FDA regulation pre-empts state litigation on the cosmetics/drugs regulatory divide. The case could have implications for the personal care industry as states increasingly claim oversight by clarifying FDA’s division between drugs and cosmetics.
Data presented at AAAI meeting show reduced annualized asthma exacerbation rates across all patient populations, but doctors are unlikely to switch patients served well by existing biologics.
The RNA drug’s accelerated approval brings Sarepta’s exon-skipping market share to nearly 30%.